Physician

Akram Audi, MD

According to 2025 Medicare claims, Akram Audi, MD (NPI: 1265841092) practices nephrology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is UNIVERSITY MEDICAL SERVICE ASSOCIATION INC (NPI: 1326088295; TIN: 23-7313346) and primary practice location at 33612-9416. Audi is affiliated with the IRCCO (ACO ID: A2619), Caravan Collaborative Pathways (ACO ID: A4604), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Audi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 1,407 HCPCS/CPT codes, and received $149,080 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,027 prescription claims across 315 beneficiaries totaling $252,654 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 54 claims. Open Payments data shows 1 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,668 to $252,654. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	255	702	$66,600
2020	429	1,720	$188,817
2021	443	1,631	$171,521
2022	462	1,436	$188,646
2023	455	1,490	$199,414
2024	435	1,407	$149,080

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	99	$2,668
2016	19	21	$1,255
2017	83	265	$13,212
2018	46	163	$12,378
2019	85	293	$10,795
2020	130	533	$34,734
2021	226	932	$172,208
2022	285	1,653	$197,328
2023	300	2,010	$146,436
2024	315	2,027	$252,654

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	33	$5,791
2024	N/R	54	$6,442

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	89	299	$260
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	51	81	$213
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	41	41	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	225	333	$59
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	66	138	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	94	5,812	$104,346
Prosol	Parenteral Amino Acid 20% No.1	150	1,037	$29,608
Kerendia	Finerenone	14	810	$16,564
Jardiance	Empagliflozin	17	870	$15,938
Sevelamer Carbonate	Sevelamer Carbonate	54	2,190	$10,405

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	15	$5,811
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$245
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	11	$224
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akram Audi, MD?

Tedicare shows public-source Medicare data for Akram Audi, MD (NPI 1265841092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akram Audi, MD have ACO affiliation data?

Akram Audi, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Akram Audi, MD?

Akram Audi, MD is linked to UNIVERSITY MEDICAL SERVICE ASSOCIATION INC (billing NPI 1326088295) in the available physician profile data.

Does Akram Audi, MD have Open Payments data?

Akram Audi, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.